Kumaril Bhargava joined Merck after serving as a Founder and Chief Executive Officer of OncoViRx, a specialty company he started after licensing compounds for blood cancer from University of Pennsylvania. Prior to OncoViRx Dr. Bhargava was part of the External Research & Development Innovation group at Pfizer where he played a key role in acquiring multiple technologies and companies in Rare and Orphan Diseases areas and establishing collaborations with biotech firms and academia. He also served as a Director of Strategic Marketing for Procrit™ at Johnson & Johnson. He has more than twenty years of experience in R&D, Supply Chain, Sales and marketing and Business development gained at Pfizer, Johnson & Johnson and Abbott.
Kumar holds a Bachelors degree in Pharmacy from Birla Institute of Technology & Science, Pilani, India a Ph.D. in Pharmaceutical Sciences and an MBA from the University of Chicago. He is a licensed pharmacist in the State of Pennsylvania and New Jersey.